All Journals > Infection Control and Hospital Epidemiology > July 2007 > Underresourced Infection Control and Prevention Programs

Article Tools

Search for Related Articles

  • By Author
  • Search In

Highlighted Article

NHSN Annual Update:
Antimicrobial-Resistant Pathogens Associated With Healthcare-Associated Infections

Annual Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006–2007

Antimicrobial-resistant pathogens that cause healthcare-associated infections (HAIs) pose an ongoing and increasing challenge to hospitals, both in the clinical treatment of patients and in the prevention of the cross-transmission of these problematic pathogens.  Describing the magnitude of the problem with respect to these antimicrobial-resistant pathogens is challenging, because the levels of antimicrobial resistance vary for different types of healthcare facilities and for different geographic areas, and some resistance phenotypes are difficult for laboratories to detect. However, the findings from such attempts may help the infection control and public health communities target problems and utilize resources more efficiently.

In the News

Featured in The Times
"Ireland 'losing war' on superbug" February 15, 2009
Challenges of Implementing National Guidelines for the Control and Prevention of Methicillin‐Resistant Staphylococcus aureus Colonization or Infection in Acute Care Hospitals in the Republic of Ireland
Fidelma Fitzpatrick, MD; Fiona Roche, PhD; Robert Cunney, MB; Hilary Humphreys, MD; Strategy for the Control of Antimicrobial Resistance in Ireland Infection Control Subcommittee
The research, published in Infection Control and Hospital Epidemiology, found one third of hospitals did not have a written policy on antibiotic use, and only 35% had an antibiotic stewardship programme.

July 2007

Volume 28, Number 7
Infect Control Hosp Epidemiol 2007;28:767–773
0899-823X/2007/2807-0001$15.00
DOI: 10.1086/518518
Original Article

Underresourced Hospital Infection Control and Prevention Programs: Penny Wise, Pound Foolish?

Deverick J. Anderson, MD, MPH;

Kathryn B. Kirkland, MD;

Keith S. Kaye, MD, MPH;

Paul A. Thacker II, BS;

Zeina A. Kanafani, MD;

Grace Auten, MD;

Daniel J. Sexton, MD

From the Division of Infectious Disease and International Health, Department of Medicine, and Duke Infection Control Outreach Network, Duke University Medical Center, Durham, North Carolina (D.J.A., K.S.K., P.A.T., Z.A.K., G.A., D.J.S.); and the Section of Infectious Diseases and International Health, Department of Medicine, Dartmouth‐Hitchcock Medical Center, Lebanon, New Hampshire (K.B.K.).

Objectives.To estimate the cost of healthcare‐associated infections (HAIs) in a network of 28 community hospitals and to compare this sum to the amount budgeted for infection control programs at each institution and for the entire network.

Design.We reviewed literature published since 1985 to estimate costs for specific HAIs. Using these estimates, we determined the costs attributable to specific HAIs in a network of 28 hospitals during a 1‐year period (January 1 through December 31, 2004). Cost‐saving models based on reductions in HAIs were calculated.

Setting.Twenty‐eight community hospitals in the southeastern region of the United States.

Results.The weight‐adjusted mean cost estimates for HAIs were $25,072 per episode of ventilator‐associated pneumonia, $23,242 per nosocomial blood stream infection, $10,443 per surgical site infection, and $758 per catheter‐associated urinary tract infection. The median annual cost of HAIs per hospital was $594,683 (interquartile range [IQR], $299,057‐$1,287,499). The total annual cost of HAIs for the 28 hospitals was greater than $26 million. Hospitals budgeted a median of $129,000 (IQR, $92,500‐$200,000) for infection control; the median annual cost of HAIs was 4.6 (IQR, 3.4‐8.0) times the amount budgeted for infection control. An annual reduction in HAIs of 25% could save each hospital a median of $148,667 (IQR, $74,763‐$296,861) and could save the group of hospitals more than $6.5 million.

Conclusions.The economic cost of HAIs in our group of 28 study hospitals was enormous. In the modern age of infection control and patient safety, the cost‐control ratio will become the key component of successful infection control programs.

Received November 1, 2006; accepted December 13, 2006; electronically published May 31, 2007.

Address reprint requests to Deverick J. Anderson, MD, MPH, DUMC Box 3824, Durham, NC 27710 ().

Cited by

Andrew F. Shorr, MD, MPH; Marya D. Zilberberg, MD, MPH; Marin Kollef, MD. (2009) Cost‐Effectiveness Analysis of a Silver‐Coated Endotracheal Tube to Reduce the Incidence of Ventilator‐Associated Pneumonia •. Infection Control and Hospital Epidemiology 30:8, 759-763
Online publication date: 1-Aug-2009.
Yin‐Yin Chen, RN, PhD; Fu‐Der Wang, MD; Cheng‐Yi Liu, MD; Pesus Chou, DrPH. (2009) Incidence Rate and Variable Cost of Nosocomial Infections in Different Types of Intensive Care Units •. Infection Control and Hospital Epidemiology 30:1, 39-46
Online publication date: 1-Jan-2009.
Deverick J. Anderson, MD, MPH; Daniel J. Sexton, MD. (2008) Whither Infection Control in Community Hospitals? Musings About the Near Future •. Infection Control and Hospital Epidemiology 29:11, 1071-1073
Online publication date: 1-Nov-2008.
Daniel P. McQuillen, Russell M. Petrak, Ronald B. Wasserman, Ronald G. Nahass, Jason A. Scull, and Lawrence P. Martinelli. (2008) The Value of Infectious Diseases Specialists: Non–Patient Care Activities. Clinical Infectious Diseases 47:8, 1051-1063
Online publication date: 15-Oct-2008.
Andrew JW Fletcher, Alison J Ruffell, Peter J Young. (2008) The LoTrach™ system: its role in the prevention of ventilator-associated pneumonia. Nursing in Critical Care 13:5, 260-268
Online publication date: 1-Oct-2008.
CrossRef
  • Presented in part: 16th Annual Meeting of the Society for Healthcare Epidemiology of America; March 18‐21, 2006; Chicago, Illinois (poster 83).

Close Popup